Loading clinical trials...
Loading clinical trials...
A Phase II Study of Proton-Based Radiation Therapy With Elective Pelvic Nodal Irradiation, Concomitant Docetaxel, and Adjuvant Androgen Deprivation for High-Risk Prostate Adenocarcinoma
The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States
Start Date
December 1, 2009
Primary Completion Date
January 1, 2015
Completion Date
April 11, 2022
Last Updated
October 3, 2023
77
ACTUAL participants
< 15% risk of + LN
RADIATION
> 15% risk of + LN
RADIATION
Lead Sponsor
University of Florida
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions